File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Current status of radio-frequency ablation for hepatocellular carcinoma

TitleCurrent status of radio-frequency ablation for hepatocellular carcinoma
Authors
KeywordsHepatocellular Carcinoma
Radio-Frequency Ablation
Issue Date2004
Citation
European Surgery - Acta Chirurgica Austriaca, 2004, v. 36 n. 5, p. 322-330 How to Cite?
AbstractBackground: Radio-frequency ablation (RFA) is the latest developed and widely practised local ablation therapy for liver tumours. It has the merit of effective tumour ablation and preservation of the maximal normal liver parenchyma. In the past few years, there has been tremendous expansion in the application of RFA for hepatocellular carcinoma (HCC) patients. However, the therapeutic effect of this local-ablation treatment needs to be balanced against its risks and possible local failure. Methods: This review focuses on the current status of RFA for HCC, with attention to its indications, approaches, risks, local failure, and survival benefit. Results: Although the results of most clinical studies of RFA seem optimistic, the associated complication and tumour recurrence should not be overlooked. Careful patient selection, meticulous RFA techniques, and prompt treatment of residual and recurrent tumours are necessary to ensure a better outcome after RFA. Conclusions: Until recently, there has been no strong evidence showing that RFA can replace any treatment modalities in the management of HCC. Nonetheless, more convincing evidence by randomised trials is required for the establishment of a treatment protocol of RFA for HCC patients.
Persistent Identifierhttp://hdl.handle.net/10722/172863
ISSN
References

 

DC FieldValueLanguage
dc.contributor.authorNg, KKen_US
dc.contributor.authorFan, STen_US
dc.date.accessioned2012-10-30T06:25:23Z-
dc.date.available2012-10-30T06:25:23Z-
dc.date.issued2004en_US
dc.identifier.citationEuropean Surgery - Acta Chirurgica Austriaca, 2004, v. 36 n. 5, p. 322-330en_US
dc.identifier.issn1682-1769en_US
dc.identifier.urihttp://hdl.handle.net/10722/172863-
dc.description.abstractBackground: Radio-frequency ablation (RFA) is the latest developed and widely practised local ablation therapy for liver tumours. It has the merit of effective tumour ablation and preservation of the maximal normal liver parenchyma. In the past few years, there has been tremendous expansion in the application of RFA for hepatocellular carcinoma (HCC) patients. However, the therapeutic effect of this local-ablation treatment needs to be balanced against its risks and possible local failure. Methods: This review focuses on the current status of RFA for HCC, with attention to its indications, approaches, risks, local failure, and survival benefit. Results: Although the results of most clinical studies of RFA seem optimistic, the associated complication and tumour recurrence should not be overlooked. Careful patient selection, meticulous RFA techniques, and prompt treatment of residual and recurrent tumours are necessary to ensure a better outcome after RFA. Conclusions: Until recently, there has been no strong evidence showing that RFA can replace any treatment modalities in the management of HCC. Nonetheless, more convincing evidence by randomised trials is required for the establishment of a treatment protocol of RFA for HCC patients.en_US
dc.languageengen_US
dc.relation.ispartofEuropean Surgery - Acta Chirurgica Austriacaen_US
dc.subjectHepatocellular Carcinomaen_US
dc.subjectRadio-Frequency Ablationen_US
dc.titleCurrent status of radio-frequency ablation for hepatocellular carcinomaen_US
dc.typeArticleen_US
dc.identifier.emailFan, ST: stfan@hku.hken_US
dc.identifier.authorityFan, ST=rp00355en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-14344262132en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-14344262132&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume36en_US
dc.identifier.issue5en_US
dc.identifier.spage322en_US
dc.identifier.epage330en_US
dc.identifier.scopusauthoridNg, KK=35248894000en_US
dc.identifier.scopusauthoridFan, ST=7402678224en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats